PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2025-01-10

Date Title Company
10-Jan-2025 1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report and Announces Management Changes AccessWire
10-Jan-2025 Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) AccessWire
10-Jan-2025 Pace(R) Life Sciences to Expand Large Molecule Development, Manufacturing, and Analytical Testing Capacity in 2025 Newswire
10-Jan-2025 New Clevorx Cold Sore Treatment Cream Offers Relief and Comfort Newswire
10-Jan-2025 Tiziana Announces Reduction of Side Effects Commonly Seen with Discontinuation of GLP-1 Agonists with Nasal Anti-CD3 Tiziana Life Sciences
10-Jan-2025 iTeos Announces 2025 Strategic Priorities and Anticipated Milestones iTeos Therapeutics
10-Jan-2025 PharmD On Demand + 340B AccessWire
10-Jan-2025 SYNBIOTIC with four new investments in 2024: Further acquisitions in sight for 2025 SYNBIOTIC SE
10-Jan-2025 Aston University researchers seek participants for newly funded study into medication weight gain Aston University
10-Jan-2025 Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations ZAGENO
10-Jan-2025 MitoRx Therapeutics Expands Leadership Team with Strategic Appointments of Chief Business Officer and Finance Director MitoRx Therapeutics
10-Jan-2025 David Schilansky Appointed Chief Financial Officer of Ariceum Therapeutics Ariceum Therapeutics
10-Jan-2025 Cytosurge Announces Strategic Leadership Transition Cytosurge AG
10-Jan-2025 Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology Synaffix B.V.
10-Jan-2025 Boehringer Ingelheim Acquires Fourth License for the Development of Novel Antibody Based Cancer Treatments from Oxford BioTherapeutics Oxford BioTherapeutics (OBT)
10-Jan-2025 Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology Boehringer Ingelheim
10-Jan-2025 PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML) PureTech
10-Jan-2025 New drug hope for prostate cancer patients The Institute of Cancer Research
10-Jan-2025 Accure Therapeutics partner Oculis reached positive phase 2 results for lead neuroprotective therapy Andrew Lloyd Associates
10-Jan-2025 Navigating the Future of Physician Practice Management - Key 2025 Trends From Black Book Surveys AccessWire